Blood test provides clues to bladder cancer patients' prognoses

New research indicates that about one-quarter of patients with bladder cancer treated with radical surgery on curative intent have detectable levels of tumour cells circulating in their blood. The presence of circulating tumour cells was also a predictor of cancer recurrence and death.

The findings suggest that testing for circulating tumour cells in patients with bladder cancer may provide insights on which patients may need to receive aggressive treatment for their disease.

"Liquid biopsies analyzing circulating in prior to radical cystectomy may be a promising assessment for selecting patients who may not be cured with surgery alone and thus are candidates for multimodal and emerging targeted therapies," said Dr. Michael Rink, senior author of the BJU International study.

Explore further

Blood test could predict best treatment for lung cancer

More information: Armin Soave et al. Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy, BJU International (2017). DOI: 10.1111/bju.13782
Provided by Wiley
Citation: Blood test provides clues to bladder cancer patients' prognoses (2017, February 13) retrieved 26 February 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments